We previously identified a naturally occurring human SNP, G247R, in the third intracellular loop of the α 1a -adrenergic receptor (α 1a -247R) and demonstrated that constitutive expression of α 1a -247R results in twofold increased cell proliferation compared with WT. In the present study we elucidate molecular mechanisms and signal transduction pathways responsible for increased cell proliferation unique to α 1a -247R, but not α 1a -WT, α 1b , or α 1d AR subtypes. We show that elevated levels of matrix metalloproteinase-7 (MMP7) and a disintegrin and metalloproteinase-12 (ADAM12) in α 1a -247R-expressing cells are responsible for EGF receptor (EGFR) transactivation, downstream ERK activation, and increased cell proliferation; this pathway is confirmed using MMP, EGFR, and ERK inhibitors. We demonstrate that EGFR transactivation and downstream ERK activation depends on increased shedding of heparin-binding EGF. Finally, we demonstrate that knockdown of MMP7 or β-arrestin1 by shRNAs results in attenuation of proliferation of cells expressing α 1a -247R. Importantly, accelerated cell proliferation triggered by the α 1a -247R is serum-and agonist-independent, providing unique evidence for constitutive active coupling to the β-arrestin1/MMP/EGFR transactivation pathway by any G protein-coupled receptor. These findings raise the possibility of a previously unexplored mechanism for sympathetically mediated human hypertension triggered by a naturally occurring human genetic variant.
T he α 1 -adrenergic receptors (α 1 AR) are G protein-coupled transmembrane receptors (GPCRs) that mediate actions of the sympathetic nervous system through binding of endogenous catecholamines epinephrine or norepinephrine. Three subtypes of α 1 ARs (α 1a , α 1b , α 1d ) exist in human tissues; upon agonist stimulation, α 1 ARs couple predominantly to the G q/11 family of G proteins. Among the three α 1 AR subtypes, α 1a ARs predominate in human vascular smooth muscle, particularly in resistant vessels (1) . Functional studies implicate α 1 ARs in human vasoconstriction, hypertension, and myocardial hypertrophy, and demonstrate an important role in regulating vascular tone (1, 2) . Supporting these observations, genetically engineered mice with targeted deletion of α 1a ARs have impaired vasopressor activity required for maintenance of normal arterial blood pressure (3) , and α 1a AR antagonists lower blood pressure when administered to humans (4) .
Stress-induced hypertrophy or increased vascular tone is characterized by changes in the structure of blood vessels and the heart. Specifically, transactivation of the EGF receptor (EGFR) by GPCRs is one potential underlying mechanism of myocardial hypertrophy (5) . Specific mechanisms by which signals are transduced from GPCRs to EGFR and downstream MAPK/ ERK cascade are beginning to be unraveled (6) . One mechanism by which cross-talk between agonist-activated GPCRs and EGFR occurs is via proteolysis of latent ligands by specific metalloproteinases (MMPs) or a disintegrin and metalloproteinases (ADAMs). MMP2, MMP7, ADAM10, ADAM12, and ADAM17 are present in arteries and have been implicated in ectodomain shedding of growth factors (7, 8) , such as heparin-binding EGF (HB-EGF), a soluble EGFR ligand generated through extracellular proteolytic cleavage of its membrane-anchored form (proHB-EGF) (9) . Binding of HB-EGF to EGFR leads to transactivation of EGFR and activation of the downstream ERK/MAPK pathway (10) . MMP/ADAM-dependent transactivation of EGFR and its contribution in the development of cardiovascular disorders is an intriguing and important research topic.
Various cardiovascular disorders, such as hypertension and heart failure, are associated with polymorphisms in genes that regulate the adrenergic system, mostly βARs and α 2 ARs (11, 12) . We identified nine naturally occurring human SNPs in the α 1a AR and characterized them pharmacologically (13) . The G247R SNP present in the third intracellular loop of the α 1a AR was originally identified in a patient with severe hypertension. Several studies suggest association of α 1a AR genetic variants with human disease, and a few report associations between α 1a AR SNPs and hypertension in humans (14, 15) .
An important feature of α 1a -247R (247R) is that it confers a proliferative advantage to cells cultured in the absence of agonist stimulation. In this study, we report that the molecular mechanism for this proliferation is G protein-independent, β-arrestin1-dependent transactivation of EGFR and activation of the downstream ERK pathway induced by elevated levels of MMP7 and ADAM12 with subsequent release of HB-EGF. This unique constitutive activation of the MMP7/ADAM12 pathway is previously undetected for GPCRs and leads to the intriguing hypothesis that this may represent a unique mechanism for sympathetically mediated hypertension triggered by a naturally occurring human genetic variant.
Results
Expression of 247R Confers Increased Cell Proliferation. The location of the G247R substitution in the third intracellular loop is schematized in Fig. 1 , showing a structural model of human α 1a AR. To expand our previous studies (13), we compared growth rates of cells expressing WT or 247R with other α 1 AR subtypes: α 1b and α 1d . Cells expressing WT, α 1b , or α 1d have comparable growth rates but 247R cells exhibit significantly higher proliferation ( Fig. 2A) .
To determine if the elevated growth rate is caused by increased affinity to serum growth factors or intrinsic signaltransduction pathways activated by 247R, cells expressing each of the α 1 ARs were cultured without serum for 24 or 48 h. Cells expressing 247R exhibit ∼twofold increased proliferation com- pared with all other α 1 ARs (Fig. 2B) . Flow cytometry analysis of cell-cycle progression of DAPI-labeled cells demonstrates that after 24 h in serum-deprived conditions (baseline), 247R cells exhibit a higher proportion of proliferating cells compared with WT (Fig. 2C) . Cell-cycle analysis at 5 and 24 h in 10% serum in the absence of agonist reveals a substantially increased proportion of proliferating cells in 247R population compared with WT (Fig. 2C ). Our findings demonstrate that expression of 247R confers a robust cell-cycle progression compared with WT, α 1b , or α 1d AR independent of serum and agonist stimulation.
To determine whether agonist-and serum-independent enhanced-proliferation of Rat-1 cells expressing 247R is cell typedependent or represents more generalizable phenomena, we established stable H9C2 rat cardiomyoblast cell lines expressing WT or 247R at low receptor densities and evaluated cell proliferation in the absence of agonist stimulation. Cells expressing 247R exhibit ∼twofold increased proliferation compared with WT or control cells (Fig. S1 ). These data demonstrate that enhanced proliferation triggered by 247R is generalizable.
Inhibition of EGFR Activity Reverses Enhanced Cell Proliferation
Induced by 247R. To determine how 247R promotes cell proliferation, we first assessed whether an EGFR autocrine pathway was involved. Activation of EGFR signaling is associated with agonist-induced hypertension and promotes proliferation, functioning upstream of MAPK (16) . EGFR transactivation depends on the activity of specific MMPs/ADAMs, which activate the latent ligands via ectodomain proteolysis (8, 17) . Therefore, we evaluated thymidine incorporation into DNA in cells treated with inhibitors to EGFR (AG1478), MMPs (GM6001), or MEK (PD98028). Cell proliferation in the presence of serum is elevated ∼twofold in 247R cells compared with WT (Fig. 3A) . Treatment of 247R cells with EGFR or MMP inhibitors reduces thymidine incorporation, but not to the level observed in WT cells (Fig. 3A) .
Because serum growth factors can activate additional proliferative pathways and partially mask the inhibitory effects of AG1478 and GM6001, we evaluated thymidine incorporation under serum-deprived conditions. Our data demonstrate a similar increase in thymidine incorporation in 247R cells compared with WT ( Fig. 3 B and C) . Importantly, treatment of 247R cells with AG1478, GM6001 ( cells, thus demonstrating that 247R-triggered serum and agonistindependent proliferation occurs via MMP-dependent transactivation of EGFR and downstream activation of ERK.
247R-Induced Cell Proliferation is Agonist-Independent. We examined the effect of phenylephrine (PE), an α 1 AR agonist, on cell proliferation and EGFR transactivation. With serum deprivation, PE slightly elevates thymidine incorporation in WT and 247R cells (Fig. 3D) . Importantly, treatment of 247R cells with PE and EGFR or MMP inhibitor results in similar reduction of cell growth as does treatment with inhibitors without PE (Fig. 3 B vs. D). These data further confirm that 247R-triggered proliferation is agonist and serum-independent. Interestingly, EGFR and MMP inhibitors reduce proliferation of WT cells, indicating PE-induced EGFR transactivation (Fig. 3D ). Neither EGFR nor MMP inhibitors affect growth rate of control cells (Fig. S2A) . PE treatment of WT and 247R cells cultured in the presence of serum significantly inhibits cell growth (Fig. S2B) , but has no effect on control cells (Fig. S2C) , consistent with agonist-induced cellcycle arrest reported for Rat-1 cells expressing WT (18) .
247R-Induced Proliferation Is a Result of Activation of ERK Through
Transactivation of EGFR. To determine involvement of ERK in 247R-induced proliferation, we immunoblotted lysates from WT or 247R cells cultured in the absence of agonist with phospho-ERK (p-ERK) antibody ( Fig. 3 E and F) . Western blotting reveals substantially increased levels of p-ERK in 247R cells (Fig. 3E , lane 4) compared with WT (Fig. 3E, lane 1) . Treatment with EGFR or general MMP inhibitor significantly reduces ERK phosphorylation in 247R cells (Fig. 3 E and F , lanes 5 and 6 vs. 4). When treated with PE, 247R cells exhibit a similar time-dependent pattern of ERK phosphorylation, again with higher levels of p-ERK compared with WT (Fig. S2D) , thus indicating that the effect of PE on ERK phosphorylation is not different for both cell types.
To determine if basal ERK activation in 247R cells is caused by MMP/EGFR transactivation, cells were treated with EGFR or MMP inhibitors, and cell lysates immunoprecipitated (see SI Methods) with EGFR antibody and immunoblotted with phosphotyrosine antibody (Fig. S3) . Compared with WT, 247R cells exhibit increased basal EGFR phosphorylation (Fig. S3, lanes 1  and 4) , and treatment with inhibitors significantly reduces EGFR phosphorylation in 247R cells (Fig. S3 , lanes 5 and 6 vs. 4). These findings reveal that 247R triggers agonist-independent (constitutive) transactivation of the MMP/EGFR pathway.
247R-Triggered EGFR Transactivation Mediated by Enhanced Shedding
of ProHB-EGF. EGFR transactivation can be induced by various stimuli including MMP-or ADAM-mediated cleavage/shedding of proHB-EGF. Because the level of soluble HB-EGF in culture medium of 247R cells is below the detection limit of the ELISA used, and other researchers have reported a similar observation (9), we initially examined Hbegf mRNA levels in WT and 247R cells. RT-PCR revealed comparable levels of Hbegf mRNA in 247R and WT cells (Fig. 4A) .
To determine whether cleavage of proHB-EGF is increased in 247R cells, lysates from serum-deprived 247R or WT cells were evaluated for the level of proHB-EGF. We observe a significant reduction (∼70%) in the amount of cell surface HB-EGF on 247R cells compared with WT (Fig. 4B) . These findings support the notion that increased shedding of proHB-EGF from 247R cells occurs and stimulates proliferation. These data suggest that reduced levels of HB-EGF in response to 247R expression is not a result of reduced expression of HB-EGF, but rather because of increased shedding and release of active HB-EGF from 247R cells.
To explore the role of HB-EGF in increased proliferation of 247R cells, WT cells were cultured in conditioned medium from 247R cells with or without immunodepletion of HB-EGF (Fig.  4C ). WT cells cultured in HB-EGF-deprived medium have ∼twofold reduced proliferation compared with medium without depletion. The growth rate was not different when cells were cultured in WT medium before or after HB-EGF depletion (Fig.  4C) . The significant reduction in proHB-EGF on 247R cells, together with reduced thymidine incorporation when WT cells are grown in HB-EGF-depleted 247R medium, indicate that 247R triggers a chain of intracellular events leading to increased shedding of HB-EGF and subsequent transactivation of EGFR, which in turn activates ERK signaling and cell proliferation.
MMP7 and ADAM12 mRNA Levels Are Increased in 247R Cells. We next assessed MMPs/ADAMs that are expressed in human vessels and may be responsible for enhanced shedding of HB-EGF from 247R cells. Mmp7 and Adam12 mRNA levels are increased in 247R cells (Fig. 4D) , but the levels of other MMPs did not differ or were reduced (Mmp2). To confirm involvement of MMP7 in increased proliferation of 247R cells, we used MMP7- (Fig. 5A) . However, the more effective shRNA1 and shRNA4 were used in subsequent experiments. Knockdown of Mmp7 mRNA with either shRNA significantly reduces cell proliferation to near normal levels as determined by thymidine incorporation assay (Fig. 5B) or cell counts (Fig. S4 ). These data demonstrate that MMP7 is responsible for shedding HB-EGF and increased proliferation of 247R cells.
Enhanced Agonist-Independent 247R Proliferation Is G Protein-Independent but β-arrestin1-Dependent. To test for classic Gq-coupled signaling effects, we investigated cell proliferation in the presence or absence of prazosin, an α 1 AR inverse agonist, or G i/o inhibitor pertussis toxin (PTX). Neither prazosin nor PTX block proliferation of WT, 247R, or control cells (Fig. 5 C and D and  Fig. S5 ). These data demonstrate that enhanced proliferation of 247R cells is not mediated by G protein-coupling, further supporting our previous report that the basal levels of IP 3 production are not different in WT or 247R cells (13) .
β-Arrestins may be involved in agonist-induced MMP-mediated EGFR transactivation and cell proliferation (19) . We assessed if the basal, serum-independent proliferation triggered by 247R is β-arrestin-dependent. Efficiency of shRNAs to reduce expression of β-arrestin1 or β-arrestin2 was determined by Western blots (Fig. 5 E and F) . Knockdown of β-arrestin1 but not β-arrestin2 reduces thymidine incorporation in 247R cells compared with scrambled shRNA transfected cells (Fig. 5G) ; in WT cells, neither had an effect. These data demonstrate that 247R-induced proliferation is β-arrestin1-dependent (Fig. 6A ).
Coimmunoprecipitation and Colocalization of 247R and β-Arrestin1.
To further confirm that 247R induced proliferation depends on constitutive interaction of 247R with β-arrestin1, we coimmunoprecipitated (co-IP) β-arrestin1 from cell lysates expressing WT or 247R (see SI Methods). The levels of β-arrestin1 is significantly higher in immunoprecipitates from 247R cells compared with WT cells cultured in the absence of PE (Fig. 5 H and I, lanes 3 and 1) . PE stimulation of 247R or WT cells does not affect this interaction (Fig. 5 H and I, lanes 3 and 4, and 1 and 2 ). These data confirm constitutive interaction between 247R and β-arrestin1 in 247R cells. To further validate these findings, we performed confocal studies using cells stably expressing WT or 247R (see SI Methods). The results demonstrate that 247R and WT are constitutively internalized consistent with a previous report for WT receptor (20) . Importantly, a distinct colocalization of β-arrestin1with 247R is observed in perinuclear region of unstimulated cells (−PE), which is not apparent in WT cells (Fig. 6B, and Fig. S6 ). Agonist stimulation of 247R cells (+PE) does not appear to alter colocalization of the receptor and β-arrestin1 (Fig. 6B, and Fig. S6 ). There is no apparent colocalization of 247R and β-arrestin2 (Fig. S7) . These data confirm constitutive recruitment of β-arrrestin1 and 247R observed in co-IP experiments.
Discussion
In the present study we found that the naturally occurring human genetic variant 247R triggers β-arrestin1/MMP7/EGFR transactivation in an agonist-independent manner. The resultant proliferative rate of 247R cells is significantly higher than that of cells expressing WT, α 1b ARs, or α 1d ARs, even in the absence of serum, findings supported by flow cytometry analysis of cell-cycle progression, thymidine incorporation, and cell counts. Furthermore, 247R-induced proliferation is normalized upon treatment with MMP or EGFR inhibitors, as well as β-arrestin1 or MMP7-specific shRNAs. Although recently agonist-independent constitutive activation of serotonin receptor was reported in transiently transfected HEK293 cells (21) , the authors did not examine whether this finding led to EFGR transactivation and cell proliferation. Thus, to our knowledge, this report of constitutive β-arrestin1/ MMP7/EGFR transactivation for any GPCR is unique.
EGFR transactivation through MMP-dependent shedding of HB-EGF by agonist activation of several GPCRs is emerging as a new, unique mechanism of growth and hypertrophy in vasculature. MMPs comprise a family of 24 or more zinc-and calciumdependent proteases, with studies revealing the role of MMPs and ADAMs in agonist-induced GPCR-mediated hypertension (7, 8) . Some proliferative effects of agonist-activated GPCRs are mediated through EGFR transactivation, often by binding to shed ligands like HB-EGF (9) . ProHB-EGF is proteolytically cleaved by specific MMPs and ADAMs to release a soluble growth factor that activates EGFR in an autocrine/paracrine manner (8, 10, 22, 23) proliferation. In this study we report that 247R cells exhibit significantly lower levels of proHB-EGF than WT cells and shed more HB-EGF into culture medium, as evidenced by HB-EGF depletion experiments, resulting in EGFR transactivation and increased proliferation. Although EGFR transactivation by some GPCRs, like angiotensin II (17), endothelin (24), or adrenergic (7, 8) receptors occurs only with agonist stimulation, our study is unique in the finding that EGFR is transactivated in 247R cells in a serum and agonist-independent manner, and this process is MMP7-dependent. This pathway and downstream ERK activation was confirmed by abrogation of increased proliferation by general MMP inhibitor or MMP7-specific shRNAs, as well as EGFR-and MEK-specific inhibitors. PE stimulation of cells cultured in serum had the expected antiproliferative effect on both cell types, consistent with a previous report (18) . Nevertheless, the proliferation rate of 247R cells was still ∼twofold higher compared with WT. In serum-deprived conditions, PE slightly increases proliferation in both cell types, and EGFR or MMP inhibitors reduce 247R cell proliferation, similar to that observed in the absence of agonist. These data further confirm constitutive agonist-independent EGFR transactivation in 247R cells. Our observations that PE-stimulated proliferation of WT cells is sensitive to EGFR and MMP inhibitors reveal agonist-dependent EGFR transactivation in WT cells. In addition to our key finding of constitutive transactivation by 247R, here we demonstrate agonist-induced α 1a -AR mediated EGFR transactivation, which has not been previously explored. Normally, in response to agonist binding, GPCRs couple to G proteins and activate downstream signaling through generation of secondary messengers. GPCR signaling is terminated by receptor phosphorylation and subsequent binding of β-arrestin, which classically desensitizes receptor and alters trafficking (25) . Recent emerging data indicate that β-arrestins can also initiate signaling in a G protein-independent manner (26, 27) . It has been shown that angiotensin receptor AT1a activates ERK by both pathways in parallel, involving β-arrestin2 and G proteinmediated signaling (28) . β-Arrestin-dependent and G proteinindependent transactivation of EGFR, and subsequent ERK activation by β 1 ARs in response to agonist stimulation, has recently been reported to be cardioprotective in mice chronically treated with catecholamines (6). In addition, it has been shown that the V2 vasopressin receptor activates ERK in a β-arrestindependent and G protein-independent manner (27) . However, this pathway was not shown to lead to increased DNA synthesis, possibly because of cytosolic retention of ERK in cells. Others report that the NK1R-β-arrestin complex does not retain activated ERK in cytosol, thus allowing nuclear translocation of ERK leading to cell proliferation (29) . It is known that GPCRs differentially interact with β-arrestin1 and -2, depending on cell type and specific receptors (30) . Differential interaction also was demonstrated in transiently transfected HEK293 cells for α 1 AR subtypes and β-arrestins (31). β-Arrestin1 and -2 have been shown to differentially interact with the third intracellular loop of GPCRs, such as muscarinic receptor (32) . It is therefore plausible that the 247R mutation resulting from substitution of a small nonpolar glycine with a larger polar arginine residue confers conformational change of the third intracellular loop of α 1a AR, facilitating its interaction with β-arrestins. Our present study reveals that knockdown of β-arrestin1 but not β-arrestin2 reduces 247R-triggerred proliferation to near normal levels, indicating that agonist and serum-independent proliferation triggered by 247R is β-arrestin1-dependent. Co-IP experiments reveal that β-arrestin1 is recruited to 247R independent of agonist treatment. These findings are consistent with constitutive colocalization of β-arrestin1 with 247R but not with WT, further confirming constitutive 247R-β-arrestin1 interaction.
It has been shown that stably expressed α 1a AR-WT constitutively internalized in Rat-1 and HEK293 cells (20, 33) , whereas there was negligible internalization observed in transiently transfected HEK293 cells (31) . α 1a AR-WT spends minimal time at the cell surface and exhibits predominantly intracellular localization in native smooth-muscle cells and hepatocytes (34) . Our data are consistent with these reports and reveal predominantly intracellular localization for both WT and 247R stably expressed at near physiological levels in Rat-1 cells. We also demonstrate that 247R is constitutively internalized and interacts with endogenous β-arrestin1 in the perinuclear region.
Failure of prazosin or PTX to inhibit increased proliferation of 247R cells indicates that 247R-triggered cell proliferation is G protein-independent. To the best of our knowledge, this report is unique in demonstrating serum and agonist-independent, β-arrestin1-dependent coupling of α 1a AR genetic variant, or any GPCR, to MMP7/ADAM12-mediated (through constitutive shedding of proHB-EGF) transactivation of EGFR and ERK activation and increased proliferation (Fig. 6A) .
In summary, our findings reveal a unique constitutive pathway activated by a naturally occurring G247R mutation in the third intracellular loop of human α 1a AR, with subsequent activation of an autocrine loop involving β-arrestin1 and MMP/ADAM-dependent EGFR transactivation in the absence of agonist or serum. Constitutive proliferation of 247R cells appears to be caused by increased levels of MMP7 and ADAM12 and subsequent shedding of HB-EGF, which together with reduced levels of MMP2 that may result in increased collagen deposition, raise the possibility that the presence of α 1a -247R in human resistance vessels might lead to alterations of blood pressure by narrowing and stiffening blood vessels (35) . These findings also raise the tantalizing hypothesis that a naturally occurring α 1a AR genetic variant may be mechanistically involved in some forms of human hypertension, and that MMP/ADAM-specific inhibitors may be effective therapeutic agents for the treatment of some forms of sympathetically mediated human hypertension.
Methods
Cell Culture. Rat-1 fibroblasts stably expressing human WT hemagglutinin (HA) epitope tagged HA-α 1a AR-WT or HA-α 1a AR-G247R (referred to as WT and 247R) were maintained as previously described (13) (see also SI Methods). Cell Cycle Analyses. Cells expressing WT or 247R were serum-starved for 24 h (baseline), followed by culturing in the absence or presence of 10% serum. Cell aliquots taken subsequently at 5 to 8 h or 22 to 24 h were labeled with a DNA-binding dye DAPI and analyzed by flow cytometry, as previously described (36) . Results are presented as the percentage of cells in different phases of the cell cycle based on their DNA content.
Molecular Modeling of α 1a AR. A structural model of human α 1a AR was generated using the Robetta protein structure prediction server (37) (see SI Methods).
Thymidine Incorporation Assay. Cells stably expressing WT or 247R were plated at 2-4 × 10 4 cells per well in 24-or 12-well plates and cultured in 10% or 0.5% serum, or in serum-deprived conditions in the presence or absence of inhibitors: 250 nM AG1478, 25 μM GM6001 (Calbiochem) or 10 μM PD98059 (Cell Signaling Technology). DMSO was used as a control vehicle. In experiments with 10 −5 Μ PE stimulation, serum-deprived cells were cultured 24 h with or without inhibitors or 10% FBS. Thymidine incorporation assays were performed as previously described (38) .
Determination of Phosphorylated ERK. Cells stably expressing WT or 247R receptors were serum-starved overnight and treated with inhibitors, as described above. In experiments with agonist stimulation, serum starvation was followed by 24-h treatment with inhibitors and10 μM PE. Western blots with p-ERK or ERK antibody were performed as previously described (38) .
RT-PCR Analysis and Transfection of Cells with shRNAs. Cells were transfected with gene specific shRNAs (SA Biosciences) using lipofectamine as described in SI Methods.
Detection of Membrane-Bound HB-EGF. To detect the proHB-EGF, the ELISA kit from R&D Systems was used. Visualization was performed using SureBlue TMB Microwell Peroxidase (KPL) as a substrate.
Cell Growth in HB-EGF-Deprived Medium. Cells expressing WT or 247R were serum deprived for 24 h, and the resultant conditioned medium was incubated in the presence or absence of HB-EGF monoclonal antibodies (R&D Systems) for 2 h at 4°C, followed by 2-h incubation with Protein A/G Sepharose beads (Santa Cruz). Beads were spun and collected medium was added onto WT cells plated in 24-well plates at 2 × 10 4 cells per well. The medium without deprivation was added into different wells of the same plate. Cells were cultured for 48 or 72 h and the thymidine incorporation assay was performed as described above.
Statistical Analysis. Quantitative analyses of p-ERK and phospho-tyrosine (pY), β-arrestin1, and HA-tagged AR levels were performed with Adobe Photoshop CS3. Statistical analysis was performed using a two-tailed Student t test.
